Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Accelerated Access Proposals Due Out Soon

Executive Summary

One aim of the soon-to-be-published proposals is to make the health environment in the UK more innovation-friendly, in particular for medtech and digital health products. The final report on the government’s Accelerated Access Review should be out by the end of the month.


Related Content

UK Accelerated Access Review Can Create A Post-Brexit 'Medtech Powerhouse'
UK Diagnostic Fret Over Loss of Support In Evidence Centers Restructure
Fees Should Be A Last Resort For NICE Funding, Says UK Medtechs
UK Life Sciences Vows To Maximize Post-Brexit Opportunities
UK Extends Device, Drug Accelerated Access Review Until April 2016





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts